US Stock MarketDetailed Quotes
LIXTW LIXTE BIOTECHNOLOGY HOLDINGS INC. WT EX
- 0.0445
- 0.00000.00%
Close Oct 15 09:30 ET
0.0000High0.0000Low
0.0000High0.0000Low0Volume0.0000Open0.0445Pre Close0.00Turnover0.00%Turnover Ratio--P/E (Static)0Shares0.110052wk High--P/B0Float Cap0.019052wk Low--Dividend TTM0Shs Float6.7700Historical High--Div YieldTTM0.00%Amplitude0.0190Historical Low--Avg Price1Lot Size
About LIXTE BIOTECHNOLOGY HOLDINGS INC. WT EX Company
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Pasadena, CA.
Company Profile
SymbolLIXTW
Company NameLIXTE BIOTECHNOLOGY HOLDINGS INC. WT EX
Listing DateNov 25, 2020
Founded2005
CEOMr. Bastiaan van der Baan
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address680 East Colorado Boulevard,Suite 180
CityPasadena
ProvinceCalifornia
CountryUnited States of America
Zip Code91101
Phone1-631-830-7092
Websitehttp://www.lixte.com
Company Executives
- Name
- Position
- Salary
- Bastiaan van der Baan
- Chairman of the Board, President and Chief Executive Officer
- 170.39K
- Dr. Jan H.M. Schellens
- Chief Medical Officer
- --
- Eric J. Forman, J.D.
- Vice President and Chief Operating Officer
- 244.46K
- Robert Neal Weingarten
- Vice President and Chief Financial Officer
- 240.64K
- Dr. Stephen J. Forman
- Independent Director
- 85.84K
- Regina Brown
- Independent Director
- 93.34K
- Dr. Yun Yen, M.D.
- Independent Director
- 93.34K
- Dr. Rene Bernards
- Independent Director
- 133.87K